ClearPoint Neuro, Inc. (NASDAQ: CLPT) is a Healthcare company (Medical - Devices) with a market capitalization of $252M. The Maz Rating grades it against the other companies in its sector.
ClearPoint Neuro, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $7.86, ClearPoint Neuro, Inc. trades at 5.6x sales and 9.0x book value. Over the last twelve months it generated about $45M of revenue and a net loss of $38M. It runs a gross margin of 61.4%, an operating margin of -70.6% and a net margin of -79.4%. It shows return on equity of -170.2%, return on invested capital of -31.1% and a free cash flow yield of -13.2%. On the balance sheet: a debt-to-equity ratio of 2.70 and a current ratio of 6.76. Over the past 52 weeks the share price ranged from $7.81 to $19.63, with a beta of 1.36.
ClearPoint Neuro, Inc. does not currently pay a dividend.
3 Wall Street analyst ratings cover the stock: 3 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.